oxallyl chloride | 155080-10-7

• 分子结构分类: 有机化合物 - 有机氧化合物 - 有机含氧阴离子化合物
• 英文名称: oxallyl chloride
• 英文别名: chlorooxyethylene；Ethenyl hypochlorite
• CAS: 155080-10-7
• 化学式: C₂H₃ClO
• 分子量: 78.4982
• InChiKey: MFXABBUXWRSTMP-UHFFFAOYSA-N

物化性质

• 沸点：
  24.8±13.0 °C(Predicted)
• 密度：
  1.055±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  4
• 可旋转键数：
  0
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  oxallyl chloride 、 trans-(1R,2R)-1-(benzyloxycarbonylamino)-2-hydroxymethyl-cyclohexane 在 二甲基亚砜 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 (1R,2R)-2-(benzyloxycarbonylamino)cyclohexanecarboxaldehyde
  参考文献：
  名称：

  Piperidine amides as modulators of chemo kine receptor activity

  摘要：

  本申请描述了公式（I）的CCR3调节剂或其药用盐形式，可用于预防哮喘和其他过敏性疾病。

  公开号：

  US20020156102A1
• 作为试剂：
  描述：

  4-(叔丁基二甲基甲硅烷基)氧代-1-丁醇 在 oxallyl chloride 、 二甲基亚砜 作用下， 以 四氢呋喃 、 正己烷 、 二氯甲烷 为溶剂， 反应 90.5h， 生成 (+/-)-7-(tert-butyldimethylsiloxy)-1-[(p-methoxybenzyl)oxy]-2-heptyn-4-ol
  参考文献：
  名称：

  A New Procedure for Construction of Oxocane and Oxonane Derivatives Based on Alkyne–Co2(CO)6 Complexes

  摘要：

  Treatment of 2-(3-hydroxy-5-phenylpent-4-yn-1-yl)-2(trimethylsilylmethyl)tetrahydrofuran (18) with Co-2(CO)(8) gave the corresponding cobalt complex, which was subsequently exposed to methanesulfonyl chloride and triethylamine in methylene chloride at refluxing temperature to provide the oxocane derivative 20 in 72% yield. This method was found to be applicable for construction of the oxonane framework. (C) 2000 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4020(99)01103-5

文献信息

• 4-Mercaptopyrrolidine derivatives as farnesyl transferase inhibitors
  申请人：Zeneca Limited

  公开号：US06232338B1

  公开（公告）日：2001-05-15

  Pharmaceutical compositions comprising an inhibitor of ras farnesylation of formula (I) wherein, R1 is for example H and further values as defined in the specification; R2 is for example H and further values as defined in the specification; R3 is for example H or a substituent having values as defined in the specification; p is 0-3 in which R3 values can be the same or different; L is a linking moiety for example —CO—NH2— and further values as defined in the specification; A is selected from phenyl; naphthyl; a 5-10 membered monocyclic or bicyclic heteroaryl ring containing up to 5 heteroatoms where the heteroatoms are independently selected from O, N and S; or a —S—S— dimer thereof when R2=H; or an enantiomer, diastereoisomer, pharmaceutically acceptable salt, prodrug or solvate thereof together with a pharmaceutically acceptable diluent or carrier. A particular use is cancer therapy.

  药物组合物包括式(I)的ras法尼酰化抑制剂，其中，R1例如为H，进一步的值如规范中定义；R2例如为H，进一步的值如规范中定义；R3例如为H或具有规范中定义的值的取代基；p为0-3，其中R3的值可以相同也可以不同；L是一个连接基团，例如—CO—NH2—和规范中定义的进一步值；A从苯基；萘基；一个含有最多5个杂原子的5-10元单环或双环杂芳基环中选择，其中杂原子独立地从O、N和S中选择；或者当R2=H时的—S—S—二聚体；或其对映体、非对映异构体、药学上可接受的盐、前药或溶剂化合物，连同药学上可接受的稀释剂或载体。一个特定用途是癌症治疗。
• Herbicidal phenylmethoxphenyl heterocycles
  申请人：FMC Corporation

  公开号：US05861359A1

  公开（公告）日：1999-01-19

  Novel herbicidal compounds, compositions containing them, and methods for their use in controling weeds are disclosed. The novel herbicidal compounds are optionally substituted phenylmethoxy or phenylmethylthio heterocycles of the formula: ##STR1## in which Q is selected from: ##STR2## R=halogen; R.sup.1 =lower alkyl, lower alkoxy, lower haloalkyl, lower haloalkoxy, lower alkylthio, lower sulfonyl, or lower alkylsulfinyl; R.sup.2 =lower alkyl, or lower haloalkyl; X=H, halogen, or lower alkyl; W=O or S; Z, Z.sup.1, Z.sup.2 are independently selected from H, halogen, straight or branched chain lower alkyl, lower alkoxy, is lower haloalkoxy, cyano, lower cyanoalkyloxy, or aryl; or Z and Z.sup.1 are adjacent to each other on the benzene ring, and taken together are --(CH.sub.2).sub.4 --; or Z.sup.2 is OA in the 2-, 3-, or 4-position of the phenyl ring; A is a derivative of an alkanoate bonded to the phenoxy oxygen at the alpha carbon; R.sup.3 is H or lower alkyl; R.sup.4 =OH or an agriculturally acceptable salt thereof, straight or branched chain lower alkoxy, lower haloalkoxy, alkoxyalkoxy, alkoxyalkoxyalkoxy, amino, lower alkylamino, lower alkylsulfonylamino, or lower (alkyl)(alkylsulfonyl)amino; and R.sup.5 =halogen or lower alkyl ester.

  揭示了新型除草化合物、含有它们的组合物以及在控制杂草中使用它们的方法。这些新型除草化合物是可选择的取代苯甲氧基或苯甲硫基杂环化合物，其化学式为：##STR1## 其中Q从以下选取：##STR2## R=卤素；R.sup.1=较低烷基、较低烷氧基、较低卤代烷基、较低卤代烷氧基、较低烷硫基、较低磺酰基或较低烷基亚砜基；R.sup.2=较低烷基或较低卤代烷基；X=H、卤素或较低烷基；W=O或S；Z、Z.sup.1、Z.sup.2独立地选自H、卤素、直链或支链较低烷基、较低烷氧基、较低卤代烷氧基、氰基、较低氰基烷氧基或芳基；或Z和Z.sup.1相邻于苯环上，一起取为--(CH.sub.2).sub.4--；或Z.sup.2是OA在苯环的2-、3-或4-位置；A是与苯氧基上的α碳键合的烷酸酯衍生物；R.sup.3=H或较低烷基；R.sup.4=OH或其农业可接受的盐，直链或支链较低烷氧基、较低卤代烷氧基、烷氧基烷氧基、烷氧基烷氧基烷氧基、氨基、较低烷基氨基、较低烷基磺酰氨基或较低(烷基)(烷基磺酰基)氨基；和R.sup.5=卤素或较低烷基酯。
• Hydroboration of Unsaturated Phosphonic Esters:  Synthesis of Boronophosphonates and Trisubstituted Vinylphosphonates
  作者：Inna Pergament、Morris Srebnik

  DOI：10.1021/ol006836o

  日期：2001.1.1

  [figure: see text] Hydroboration of vinyl phosphonates with pinacolborane (PBH) proceeds to give phosphonoboronates, 2. Surprisingly, such compounds have not been reported before. The reaction works well with terminal alkenylphosphonates. Internal alkenylphosphonates give complex mixtures. Hydroboration/Suzuki coupling of alkynylphosphonates, with PBH, in a one-pot procedure gives trisubstituted vinylphosphonates

  [图：见正文]用频哪醇硼烷（PBH）对膦酸乙烯基酯进行氢硼化可得到膦酰基硼酸酯2。令人惊讶的是，此类化合物以前尚未见报道。该反应与末端烯基膦酸酯一起很好地进行。内部链烯基膦酸酯产生复杂的混合物。单锅法将炔基膦酸酯与PBH进行硼氢化/铃木偶联，可得到具有良好总收率的三取代乙烯基膦酸酯，并提供了这些化合物的新合成方法。
• Nitrogen containing heterobicycles as factor Xa inhibitors
  申请人：Bristol-Myers Squibb Pharma Company

  公开号：US06413980B1

  公开（公告）日：2002-07-02

  The present application describes nitrogen containing heterobicyclics and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.

  本申请描述了含氮杂双环化合物及其衍生物，或其药用盐形式，这些化合物可作为因子Xa的抑制剂。
• Piperidine amides as modulators of chemo kine receptor activity
  申请人：——

  公开号：US20020156102A1

  公开（公告）日：2002-10-24

  The present application describes modulators of CCR3 of formula (I): 1 or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.

  本申请描述了公式（I）的CCR3调节剂或其药用盐形式，可用于预防哮喘和其他过敏性疾病。